iop
09.24.20
Aerie Pharmaceuticals Announces Interim 90-Day Topline Data From Its 6-Month Mercury 3 Clinical Trial in EuropeSource: Aerie Pharmaceuticals
09.01.20
Injectsense Receives Breakthrough Device Program Designation From FDA for IOP Monitoring SystemSource: Injectsense
03.11.20
Reichert Technologies Signs Exclusive Deal for CATS Reusable Tonometer PrismsSource: Reichert Technologies
01.02.20
Aerie Pharmaceuticals Announces Acceptance for Review of the Roclanda Marketing Authorization Application in EuropeSource: Aerie Pharmaceuticals
11.05.19
Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil in Phase 2 Study Conducted in JapanSource: Aerie Pharmaceuticals